Medicine and Dentistry
Adipose Tissue
5%
Adverse Event
13%
Aerobic Exercise
7%
Alzheimer's Disease
11%
Apoplexy
9%
Aquaporin 4 Antibody
15%
Biological Marker
6%
Botulinum Toxin A
10%
Cannabis
5%
Cardiac Fibrosis
6%
Cardiovascular Disease
11%
Cardiovascular Risk
6%
Care Coordination
5%
Cataract
10%
Clinical Research
5%
Clinical Trial
5%
Cohort Analysis
24%
Communicable Disease
5%
Congestive Heart Failure
8%
Cord Blood
5%
COVID-19
17%
Cross Sectional Study
6%
Demography
5%
Diabetes
12%
Diagnosis
6%
Diastolic Function
5%
Disability Adjusted Life Years
5%
Disability Pension
5%
Disease
44%
Disease Activity
13%
Drug Therapy
7%
Empagliflozin
10%
Expanded Disability Status Scale
7%
Fumaric Acid Dimethyl Ester
10%
Ganglion
12%
Global Disease Burden
43%
Hazard Ratio
6%
Heart Muscle Blood Flow
10%
Hemodynamic
5%
Informal Carer
5%
Injury
6%
Inner Plexiform Layer
12%
Kinesiotherapy
10%
Life Expectancy
6%
Maternal Blood
5%
Maturity Onset Diabetes of the Young
20%
Medical Research
5%
Medicine
5%
Meningitis
6%
Mental Capacity
5%
Mental Health Care
5%
Meta-Analysis
19%
microRNA
5%
Mitochondrion
5%
Multiple Chronic Conditions
12%
Multiple Sclerosis
45%
Myeloid Cell
5%
Neurofilament
5%
Neuroinflammation
5%
Neuromyelitis Optica
65%
Neuropathic Pain
5%
Obstetrics
5%
Onset Age
6%
Optic Neuritis
18%
Optical Coherence Tomography
22%
Outer Plexiform Layer
5%
Parkinson's Disease
5%
Patient with Type 2 Diabetes
21%
Patient-Reported Outcome
12%
Personalized Medicine
5%
Placebo
11%
Population Research
6%
Prevalence
11%
Primary Health Care
10%
Progeny
6%
Prognostication
5%
Prospective Cohort Study
5%
Quality of Life
15%
Randomized Clinical Trial
9%
Randomized Controlled Trial
22%
Recurrence Risk
6%
Respiratory Tract Infection
6%
Retinal Nerve Fiber Layer
13%
Semaglutide
5%
Sequential Analysis
10%
Sex Ratio
5%
Shared Care
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Spasmodic torticollis
5%
Spasticity
5%
Spinal Cord Injury
8%
Subclinical Hypothyroidism
10%
Systematic Review
11%
Systematic Review with Meta-Analysis
10%
Systolic Dysfunction
5%
Teriflunomide
10%
Thyroid Gland
5%
Type 2 Diabetes
7%
Vascular Dementia
5%
Water-Electrolyte Imbalance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
14%
Alzheimer's Disease
7%
Aquaporin 4 Antibody
8%
Botulinum Toxin A
10%
Cannabis
5%
Cardiovascular Disease
5%
Cataract
5%
Cerebrovascular Accident
9%
Cervical Dystonia
5%
Citalopram
5%
Clinical Research
5%
Clostridium Botulinum Type A
7%
Cohort Study
11%
Communicable Disease
5%
Comorbidity
8%
Complex Regional Pain Syndrome
5%
Cross-Sectional Study
5%
Diabetic Complication
5%
Diabetic Ketoacidosis
5%
Disease
39%
Disease Activity
7%
Disease Exacerbation
7%
Empagliflozin
5%
Expanded Disability Status Scale
9%
Fumaric Acid Dimethyl Ester
10%
Global Disease Burden
49%
Hearing Impairment
5%
Heart Muscle Fibrosis
5%
Inflammatory Disease
6%
Injury
5%
Insulin Dependent Diabetes Mellitus
5%
Life Expectancy
6%
Meningitis
6%
microRNA
5%
Multiple Sclerosis
35%
Myelin Oligodendrocyte Glycoprotein
5%
Myelooptic Neuropathy
52%
Neuropathic Pain
5%
Neurotoxin
5%
Non Insulin Dependent Diabetes Mellitus
23%
Onset Age
5%
Pandemic
6%
Parkinson's Disease
9%
Placebo
14%
Prevalence
16%
Prospective Cohort Study
5%
Recurrence Risk
5%
Respiratory Tract Infection
6%
Rituximab
7%
Semaglutide
5%
Sodium Glucose Cotransporter 2
5%
Spasticity
5%
Spinal Cord Injury
8%
Subclinical Hypothyroidism
10%
Systolic Dysfunction
5%
Teriflunomide
10%
Tetramethylrhodamine Methyl Ester
5%
Vitamin D
5%
Neuroscience
Adipose Tissue
5%
Alzheimer's Disease
6%
Amyotrophic Lateral Sclerosis
5%
Angiotensin II Receptor Type 2
10%
Aquaporin 4
17%
Aquaporin 4 Antibody
17%
Astrocyte
19%
Autoantibodies
7%
Behavior (Neuroscience)
6%
Brain-Derived Neurotrophic Factor
5%
Cannabis
5%
Central Nervous System
9%
Cerebrovascular Accident
10%
Clostridium Botulinum Type A
5%
Cognitive Therapy
5%
Comorbidity
7%
CXCL13
5%
Demyelinating Disease
10%
Ganglion Cell
6%
Glial Fibrillary Acidic Protein
7%
Hypertension
5%
Hypothyroidism
11%
Immunoglobulin G
9%
Interferon
6%
Interleukin 10
6%
Intrathecal
9%
Magnetic Resonance Imaging
6%
Meta-Analysis
10%
Methyl Ester
5%
Microglia
6%
MicroRNA
5%
Mitochondrion
6%
Multiple Sclerosis
47%
Myelin Oligodendrocyte Glycoprotein
14%
Nerve Fiber
7%
Neuritis
5%
Neurofilament
5%
Neuromyelitis Optica
100%
Neuropathic Pain
5%
Optic Nerve
6%
Optic Neuritis
49%
Parkinson's Disease
10%
Placebo
6%
Rituximab
7%
Secondary Progressive Multiple Sclerosis
5%
Sensation of Hearing
5%
Teriflunomide
5%
Thyroid
5%